This CRC subgroup has an extremely low frequency of TP53 mutation, and displays overexpression of MDM2 and normal expression of p21, suggesting that deregulation of p53 pathway in this CRC subgroup may be due to other alternative mechanisms than TP53 mutation. Here, TP53 is linked to colorectal carcinoma.